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Police investigation revealed that the man searched the internet for 
information on new psychotropic substances, among others about U-47700. A 
powder found in the victims home was transferred to the laboratory for 
analysis, in which trace amounts of fentanyl (35 mg/kg) and U-47700 (12 
mg/kg) were identified by gas chromatography mass spectrometry.  
U-47700 is an opioid analgesic drug, considerd to have a potency of 
approximately 7.5 times that of morphine. A target analysis on U-47700 
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chromatography tandem mass spectrometry operating in multiple reaction 
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1.Introduction  
The intoxication appeared in January 2016. The following situation was found at the scene: a 
30-year old man was found dead in his home, on the ground of a small enclosed storage room. 
He was dressed, lying on his left side with raised knees, the left arm in extension and his right 
arm in flexion. The right hand was lying on the left elbow and was holding a lighter. Next to 
the right leg, a piece of kitchen foil was present; the bottom blackened (burned) and a brown 
residu on the upper side. The victim was a well-muscled man of normal build. He weighted 
approximately 70 kg and was 179 cm tall. On careful examination, no injection sites or 
traumatic injuries were found. Death appeared at least 48 h before and pulmonary oedema 
was observed.  
Drug paraphernalia were present on the table in the living room: a recent delivered envelope  
from China, a white powder (36 gram), a digital scale and spoon. The police investigation 
revealed that, among his friends, the man was know to abuse illegal drugs and experiment 
with substances purchased over the internet. On his mobile device a search history for the 
purchase of carfentanil and U-47700 over the internet was found.  
 
2. Materials and Methods 
2.1 Materials 
Reference U-47700 (molecular formula: C16H22Cl2N2O; molecular weight: 329.26 g/mol; 
chemical structure shown in Figure1.) was kindly provided by the Belgium Early Warning 
System on Drugs. The reference material of the internal standard fentanyl-d5 (100 µg/mL in 
methanol) was obtained from Cerilliant. Standard compounds were diluted in methanol and 
stored at – 18 °C. All other chemicals were analytical grade. 
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2.2 Apparatus  
The target analysis on the presence of U-47700 was performed by UPLC-MS/MS, using a 
Acquity separations module coupled to the Acquity TQD mass detector equipped with ES 
interface (Waters Milford, MA, USA). Chromatographic separation was achieved using a 
Acquity UPLC HSS C18 column (150-mm length x 2.1 mm i.d., 1.8 µm particle size) with a 
HSS C18 Vanguard column (5-mm length x 2.1 mm i.d., 1.8 µm particle size) as guard 
column at 50 °C. The mobile phases consisted of 0.15% formic acid (A) and 0.15% formic 
acid in acetonitrile (B). The following gradient elution was used  (runtime 15.00 min): at time 
0 min. 13% B held for 0.50 min., changed to 50 % B in 9.50 min., changed to 95 % B in 0.75 
min and held for 1.50 min., changed back to the initial conditions in 0.25 min and held for 
2.50 min. The flow rate was 0.400 mL/min. The electrospray source was operated  in the 
positive ionisation mode. Product ions were obtained by collision-induced dissociation 
allowed the MS/MS to be operated in the multiple reaction monitoring (MRM) mode. The 
MRM transitions and conditions for the measurement of U-47700 (retention time: 6.55 min.); 
330.20/285.20 (qualifier) and 330.20/173.20; cone voltage 28 V; collision energy 15 V and 28 
V respectively; fentanyl-d5 (retention time: 6.51 min.): 345.42 /188.25 (qualifier) and 
342.42/105.10; cone voltage 40 V; collision energy 25 V and  28 V  respectively. 
Quantitations were carried out using the first transition (qualifier). For confirmation, the 
percent ratio of the second transition to the qualifier was calculated and monitored. The 
source temperature and desolvation gas (nitrogen) temperature were set at 150 °C and 400 °C, 
respectively. The gas flow was delivered at a rate of 800 L/h. The capillary voltage was 3.00 
kV. Waters Mass-lynx system software Version 4.1 was used for instrument control and 
quantitation. The method validation was based on the document ‘Standard Practices of 
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Method Validation in Forensic Toxicology’ published by the Scientific Working Group of 
Forensic Toxicology [1].  
 
2.3 Samples 
Only an external body examination was ordered by the magistrate during which subclavian 
blood (left) and urine were sampled by the medical examiner. Approximately 2 g of the 
powder was submitted to the laboratory for analysis. The tissue samples were stored at -18 °C 
for 2 weeks before quantitation was performed. 
 
3. Methods 
Systematic toxicological analysis 
The blood and urine were submitted to a comprehensive systematic analysis for the detection 
of alcohol and volatiles, CO and CN, medical and illegal drugs and new psychotropic 
substances (previously detected in ‘regional’ seizures) using different extraction procedures 
and analytical techniques including headspace gas chromatography with flame ionization 
detector, liquid chromatography with diode array detector (HPLC/PDA), gas chromatography 
mass spectrometry in full scan mode (GC/MS), presumptive colour test and several methods 
applying ultra performance liquid chromatography mass spectrometry in multiple reaction 
monitoring mode (on blood and enzyme hydrolyzed urine). The method for the quantitation of 
fentanyl and norfentanyl was previously described [2]. The white powder was subjected to the 
authors identification scheme (ISO/IEC 17025:2005 accreditated) based on HPLC/PDA and 
GC/MS. 
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Sample preparation and extraction 
For the quantitation of U-47700 in blood and urine, the liquid-liquid extraction was applied as 
described for fentanyl and norfentanyl [2]:  to a 0.5 mL aliquot of sample (blood or enzyme 
hydrolyzed urine), 5 µL of internal standard solution (fentanyl-d5 0.5 µg/mL in methanol) 
was added. After addition of the internal standard solution, the samples were vortex mixed 
and allowed to equilibrate 30 min. prior to extraction. Alkalinization was obtained by addition 
of 1.0 mL 1 M potassium carbonate solution followed by agitation on a vortex mixer. 
Extraction was performed with 5 mL of a mixture of n-hexane: ethyl acetate (7:3, v/v). After 
vortex mixing during 2 min. and centrifugation at 3000 rpm for 5 min., the upper organic 
layer was evaporated  to dryness under a slow stream of nitrogen at 40 °C. The dried extracts 
were reconstituted in 0.25 mL of initial mobile phase. The reconstituted tissue extracts were 
centrifuged at 14000 rpm for 5 min. A 10 µL aliquot was injected into the UPLC-MS/MS 
system. A blank was injected before every sample. Calibrators and quality controls were 
prepared by addition of standard solution to blanc whole blood prior to extraction. Calibrators 
and controls were different preparations of the same drug standard lot. Samples were analyzed 
in triplicate and mean values are given. Two aliquots of the powder (approximately 100 mg 
weighted in a 10 ml volumetric flasked) were extracted with methanol. Three volumes of each 
flask were quantitated by UPLC/MS-MS.  
 
3 Toxicological results 
The comprehensive systematic toxicological analysis showed the presence of 10.9 µg/L 
fentanyl and a therapeutic level of 0.18 mg/L sertraline (HPLC/PDA) in the subclavian blood. 
Fentanyl and sertraline were identified in the alkaline extract of the urine analyzed on 
GC/MS. The target analysis performed by UPLC-MS/MS revealed the presence of U-47700 
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at a concentration of 13.8 µg/L in blood and 71.0 µg/L in urine. An overview of the assessed 
validation parameters and validation data are shown in Table 1. No another compounds were 
detected which contributed to the death of the man. Fentanyl and U-47700 were identified in 
the alkaline extract of the powder analyzed by GC/MS, based on retention time and spectrum 
match with the reference. Quantitative results were obtained with UPLC-MS/MS: 35 mg/kg 
for fentanyl and 12 mg/kg for U-47700 by analysis of methanolic sample extracts (y= 1730.15 
x + 1807.62, r2 = 0.999046). 
 
4 Discussion 
Fentanyl and U-47700 are µ-opioid receptor agonists. Fentanyl (N-phenyl-N-(1-2-
phenylethyl-4-piperidyl)propanamide) is a synthetic narcotic analgesic which was first 
synthezised by Janssen in 1959 and is widely used for the management of chronic pain. In 
literature, a great number of fentanyl intoxications are reported due to improper use of 
transdermal therapeutic patches such as overuse, inhalation, intraveneous or buccal abuse [2-
9]. U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) is a opioid 
developed by Upjohn in the 1970s, which has never been studied in humans and its not 
approved for medical use. Very little, if any, information is available from scientific literature 
[10]. The substance is openly sold on the internet. Anecdotal evidence can be derived from 
user reports found on the internet. From these ‘trip reports’, it is obvious that this compound 
is being used as a ‘legal’ substitute for other strong opioids, such as morphine, heroin or even 
fentanyl [11]. U-47700 is only controlled in Finland and Sweden (the latter since 26/01/2016). 
Fentanyl  is 75 to 100 times more potent and U-47700 is approximately 7.5 times more potent 
than morphine, making the abuse in the recreational drug scene very dangerous due to the 
narrow range between its effective dose and lethal dose, in particular in opioid intolerant 
users. In opioid naive patients, the minimum effective analgesic serum concentrations of 
6 
 
fentanyl range from 0.2 to 1.2 µg/L. With serum concentration greater than 2 µg/L, the risk of 
hypoventilation increases [12]. It is thought that the same health risks apply for U-47700 as 
for other strong opioids such as fentanyl and heroin, including respiratory arrest/depression, 
miosis, constipation, coma. Very high dosages might result in death, probably due to 
respiratory arrest and pulmonary oedema. In the reported case, the latter was observed at the 
external body examination. 
Based on the crime scene findings, it was concluded that the route of administration was 
inhalation of the vaporized substances. The aluminium foil with brown residu from the scene 
was not available for analysis. No other packages or powders were found in the victims home. 
Due to the low toxic concentration of fentanyl and U-47700 in blood, target analysis and 
hyphenated techniques needed to be applied for the identification and quantitation [13]. The 
recognition and analysis of highly potent, new psychotropic substances (NPS) in tissues are 
challenging in postmortem toxicology. A multidisciplinary approach with exchange of 
circumstantial evidence is vital, as experienced in this and previous cases [14]. The powder 
was found to be insoluble in methanol and ultrapure water (native and alkaline). The powder 
needed to be extracted under alkaline conditions (pH 9) with diethylether and the extract 
concentrated to obtain an identification by GC/MS and HPLC/PDA. Fentanyl was initialy 
identified on GC/MS by means of computer based library search of the SWGDRUG Mass 
Spectral Library (Version 2.4) installed on the Agilent Chemstation. Neither a library hit, nor 
a reference mass spectrum of U-47700 was found in literature. The chromatogram of the 
alkaline extract of the powder, with mass spectra of  U-47700 from the powder and reference 
is shown in Figure 2. The UV-spectrum of U-47700 is given in Figure 3. Fentanyl and U-
47700 in the powder were quantitated by UPLC/MS-MS and were 35 mg/kg and 12 mg/kg, 
respectively. 
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Based on the circumstantial evidence (police investigation, crime scene) and the results of the 
toxicological analysis, we concluded that the man’s death was caused by acute intoxication 
with fentanyl and U-47700 immediately after inhaling the fumes of the powder. The manner 
of death was presumed to be accidental due to excessive combined abuse of fentanyl and U-
47700. The substances were purchased over the internet as NPS. 
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Figure 1. Chemical structure of U-47700 
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Figure 2. Chromatogram of the alkaline extract of the powder with internal standard 
diphenylamine (upper), mass spectra of  U-47700 from the powder (middle) and reference 
(below) 
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Figure 3. UV spectrum of U-47700 
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Table 1. Validation parameters and Validation data 
Validation parameter  Validation data 
Calibration model unweighted linear curve fit 
mean correlation coefficient (r): 0.9997 
residual plots were evaluated, confirming that the used 
calibration model was appropriate 
calibration range:  1.6 µg/L – 63.5 µg/L (six point 
calibration curves) 
Bias  at concentration low (6.4 µg/L): 1.1 % 
at concentration high (47.6 µg/L): 0.9 % 
Precision 
  
within-run CV:  5.6 % (low), 3.8 % (high) 
between-run CV: 3.7 % (low), 2.9 % (high) 
Carryover no carryover was observed after highest calibrator 
Interference studies no interfering signal from matrix, internal standard, 
common drugs abuse (including other common 
opiates/metabolites) and prescription medications 
Ionization 
suppression/enhancement 
post-extraction addition approach:   
+ 2.5 % (1.9 % CV) at concentration low 
+ 1.4 % (4.5 % CV) at concentration high 
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Limit of detection (LOD) / limit 
of quantitation (LOQ) 
value of lowest non-zero calibrator (1.6 µg/L) 
 
